Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 29;55(1):12–23. doi: 10.1080/07853890.2022.2148733

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 3. — Risk of dying by subphenotype in those who did (blue bars) and did not (red bars) receive convalescent plasma. Robust Poisson regression models adjusted for onset time, hospital, self-identified race/ethnicity and insurance provider stratified by receiving convalescent plasma versus not. P-interaction terms generated by robust Poisson multivariable regression with introduction of an interaction term. P-interaction terms of less than 0.10 are shown. Hypoinflam.: Hypoinflammatory; Mod inflam. Fever: Moderate inflammation with fever; Hyperinflam. Liver dysfunc.: Hyperinflammatory with liver dysfunction; Mod inflam. Coagulopathy: Moderate inflammation with coagulopathy; Hyperinflam. Renal dysfunc: Hyperinflammatory with renal dysfunction; Hyperinflam. Multiorgan dysfunc.: Hyperinflammatory with multiorgan dysfunction. Number at risk per subphenotype (those who received convalescent plasma/those who did not): Hypoinflammatory (2/19), Moderate inflammation, fever (10/82), Hyperinflammatory, liver dysfunction (18/179), Moderate inflammation, coagulopathy (25/253), Hyperinflammatory, renal dysfunction (11/186), Hyperinflammatory multiorgan dysfunction (27/530).